...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith News
Reply New Message
Back To Forum List View

https://finance.yahoo.com/news/zenith-announces-extension-filing-calendar-220000047.html

2 Recommendations
Re: Zenith News
1
noretreat
Aug 27, 2020 08:12AM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply